450 related articles for article (PubMed ID: 11868797)
1. Trough:peak ratio and smoothness index in the evaluation of 24-h blood pressure control in hypertension: a comparative study between valsartan/hydrochlorothiazide combination and amlodipine.
Palatini P; Malacco E; Di SS; Carretta R; Dorigatti F; Bertocchi F; Mann J
Eur J Clin Pharmacol; 2002 Jan; 57(11):765-70. PubMed ID: 11868797
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the effects on 24-h ambulatory blood pressure of valsartan and amlodipine, alone or in combination with a low-dose diuretic, in elderly patients with isolated systolic hypertension (Val-syst Study).
Palatini P; Mugellini A; Spagnuolo V; Santonastaso M; Ambrosia GB; Caiazza A; Malacco E;
Blood Press Monit; 2004 Apr; 9(2):91-7. PubMed ID: 15096906
[TBL] [Abstract][Full Text] [Related]
3. A multicenter, randomized double-blind study of valsartan/hydrochlorothiazide combination versus amlodipine in patients with mild to moderate hypertension.
Palatini P; Malacco E; Fogari R; Carretta R; Bonaduce D; Bertocchi F; Mann J; Condorelli M;
J Hypertens; 2001 Sep; 19(9):1691-6. PubMed ID: 11564991
[TBL] [Abstract][Full Text] [Related]
4. Differential time effect profiles of amlodipine, as compared to valsartan, revealed by ambulatory blood pressure monitoring, self blood pressure measurements and dose omission protocol.
Radauceanu A; Boivin JM; Bernaud C; Fay R; Zannad F;
Fundam Clin Pharmacol; 2004 Aug; 18(4):483-91. PubMed ID: 15312156
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
[TBL] [Abstract][Full Text] [Related]
6. Effects of valsartan/hydrochlorothiazide and amlodipine on ambulatory blood pressure and plasma norepinephrine levels in high-risk hypertensive patients.
Malacco E; Piazza S; Scandiani L; Zoppi A
Adv Ther; 2004; 21(3):149-61. PubMed ID: 15509131
[TBL] [Abstract][Full Text] [Related]
7. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F
Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
[TBL] [Abstract][Full Text] [Related]
8. Ambulatory blood pressure response to once-daily fimasartan: an 8-week, multicenter, randomized, double-blind, active-comparator, parallel-group study in Korean patients with mild to moderate essential hypertension.
Lee H; Kim KS; Chae SC; Jeong MH; Kim DS; Oh BH
Clin Ther; 2013 Sep; 35(9):1337-49. PubMed ID: 23932463
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of valsartan/hydrochlorothiazide fixed-dose combination compared with amlodipine monotherapy as first-line therapy for mild to moderate hypertension.
Chao CL; Lin YH; Lin LC; Lin LY; Tsai CT; Wang YC; Hwang JJ; Chen JC; Chiang FT
J Int Med Res; 2009; 37(2):289-97. PubMed ID: 19383221
[TBL] [Abstract][Full Text] [Related]
10. Triple antihypertensive therapy with amlodipine, valsartan, and hydrochlorothiazide: a randomized clinical trial.
Calhoun DA; Lacourcière Y; Chiang YT; Glazer RD
Hypertension; 2009 Jul; 54(1):32-9. PubMed ID: 19470877
[TBL] [Abstract][Full Text] [Related]
11. Real-world effectiveness of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide in high-risk patients and other subgroups.
Assaad-Khalil SH; Najem R; Sison J; Kitchlew AR; Cho B; Ueng KC; DiTommaso S; Shete A
Vasc Health Risk Manag; 2015; 11():71-8. PubMed ID: 25653536
[TBL] [Abstract][Full Text] [Related]
12. A comparison of the effects of fixed dose vs. single-agent combinations on 24-h blood pressure variability.
Ulusoy S; Ozkan G; Konca C; Kaynar K
Hypertens Res; 2012 Nov; 35(11):1111-7. PubMed ID: 22786565
[TBL] [Abstract][Full Text] [Related]
13. Effects of force-titrated valsartan/hydrochlorothiazide versus amlodipine/hydrochlorothiazide on ambulatory blood pressure in patients with stage 2 hypertension: the EVALUATE study.
Lacourcière Y; Wright JT; Samuel R; Zappe D; Purkayastha D; Black HR;
Blood Press Monit; 2009 Jun; 14(3):112-20. PubMed ID: 19384192
[TBL] [Abstract][Full Text] [Related]
14. Office and ambulatory blood pressure-lowering effects of combination valsartan/hydrochlorothiazide vs. hydrochlorothiazide-based therapy in obese, hypertensive patients.
Raij L; Egan BM; Zappe DH; Purkayastha D; Samuel R; Sowers JR
J Clin Hypertens (Greenwich); 2011 Oct; 13(10):731-8. PubMed ID: 21974760
[TBL] [Abstract][Full Text] [Related]
15. Randomized, double-blind, crossover comparison of amlodipine and valsartan in african-americans with hypertension using 24-hour ambulatory blood pressure monitoring.
Maciejewski S; Mohiuddin SM; Packard KA; Mooss AN; Reyes AP; Aryana A; Hilleman DE
Pharmacotherapy; 2006 Jul; 26(7):889-95. PubMed ID: 16803420
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of two treatment combinations of hypertension in very elderly patients.
Fogari R; Zoppi A; Mugellini A; Corradi L; Lazzari P; Preti P; Derosa G
Arch Gerontol Geriatr; 2009; 48(3):401-5. PubMed ID: 18457886
[TBL] [Abstract][Full Text] [Related]
17. 24-Hour ambulatory blood pressure control with triple-therapy amlodipine, valsartan and hydrochlorothiazide in patients with moderate to severe hypertension.
Lacourcière Y; Crikelair N; Glazer RD; Yen J; Calhoun DA
J Hum Hypertens; 2011 Oct; 25(10):615-22. PubMed ID: 21248785
[TBL] [Abstract][Full Text] [Related]
18. Ambulatory blood pressure response to triple therapy with an angiotensin-receptor blocker (ARB), calcium-channel blocker (CCB), and HCTZ versus dual therapy with an ARB and HCTZ.
Duprez D; Ferdinand K; Purkayastha D; Samuel R; Wright R
Vasc Health Risk Manag; 2011; 7():701-8. PubMed ID: 22174580
[TBL] [Abstract][Full Text] [Related]
19. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
Poldermans D; Glazes R; Kargiannis S; Wernsing M; Kaczor J; Chiang YT; Yen J; Gamboa R; Fomina I
Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820
[TBL] [Abstract][Full Text] [Related]
20. Double-blind, randomized, multicentre comparison of the effects of amlodipine and perindopril on 24 h therapeutic coverage and beyond in patients with mild to moderate hypertension. General Physicians Investigators' Group.
Zannad F; Bernaud CM; Fay R
J Hypertens; 1999 Jan; 17(1):137-46. PubMed ID: 10100105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
